Catalyst Pharma (CPRX) Regains Listing Compliance with Nasdaq Minimum Bid Rule

August 3, 2012 9:06 AM EDT Send to a Friend
Get Alerts CPRX Hot Sheet
Trade CPRX Now!
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced today that it has received notice from the NASDAQ Stock Market ("NASDAQ") confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on the NASDAQ Capital Market.

As previously announced on June 21, 2012, NASDAQ notified the Company that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days and, as a result, the Company was not in compliance with Listing Rule 5550(a)(2)("Rule"). The Company was provided 180 calendar days, or until December 17, 2012, to regain compliance with the Rule.

On August 2, 2012, NASDAQ notified the Company that the closing bid price of its common stock has been at $1.00 per share or greater for at least 10 consecutive business days. Accordingly, NASDAQ has confirmed to the Company that it has regained compliance with the minimum bid price rule and the matter is now closed.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Corporate News

Add Your Comment